1
6
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T26889 |
Borofalan(10B)
L-4-Boronophenylalanine,4-10硼酸-L-苯丙氨酸 |
Others | Others |
Borofalan(10B) (L-4-Boronophenylalanine) 具有抗肿瘤作用,可用于研究复发性或局部晚期头颈癌。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01884 |
MMP-8 Protein, Human, Recombinant
CLG1,HNC,PMNL-CL,matrix metallopeptidase 8,MMP-8 |
Human | HEK293 Cells |
MMP-8 Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 52 kDa and the accession number is P22894. | |||
TMPK-01286 |
MMP-8 Protein, Cynomolgus, Recombinant (His)
Collagenase 2,HNC,CLG1,MMP8,PMNL-CL |
Cynomolgus | HEK293 Cells |
Alteration of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) expression has been studied for various cardiac diseases, including dilated cardiomyopathy (DCM), with the significance of surrogate markers of extracellular matrix (ECM) remodeling. MMP-8 was identified only in myocardiocytes, while MMP-9 and TIMP-2 were present in both myocardiocytes and stroma, but with different intensity. The increasing intensity of MMP-8 and TIMP-2 immunoreactions was signifi... | |||
TMPY-01377 |
MMP-8 Protein, Human, Recombinant (His)
MMP-8,HNC,matrix metallopeptidase 8,CLG1,PMNL-CL |
Human | HEK293 Cells |
MMP-8 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 52.6 kDa and the accession number is P22894. | |||
TMPK-00726 |
DSG3 Protein, Mouse, Recombinant (His)
SG3,PVA,DSG3,CDHF6,Desmoglein-3,DSG-3 |
Mouse | HEK293 Cells |
To identify genes that could potentially serve as molecular therapeutic markers for human head and neck cancer (HNC),DSG3 is identified overexpressed in HNC, with the degree of overexpression associated with clinicopathologic features of the tumor. Inhibition of DSG3 significantly suppresses carcinogenic potential in cellular and in vivo animal studies. DSG3 is a potential molecular target in the development of adjuvant therapy for HNC. DSG3 Protein, Mouse, Recombinant (His) is expressed in HEK2... | |||
TMPK-00871 |
DSG3 Protein, Human, Recombinant (His)
CDHF6,SG3,DSG-3,DSG3,Desmoglein-3,PVA |
Human | HEK293 Cells |
To identify genes that could potentially serve as molecular therapeutic markers for human head and neck cancer (HNC),DSG3 is identified overexpressed in HNC, with the degree of overexpression associated with clinicopathologic features of the tumor. Inhibition of DSG3 significantly suppresses carcinogenic potential in cellular and in vivo animal studies. DSG3 is a potential molecular target in the development of adjuvant therapy for HNC. DSG3 Protein, Human, Recombinant (His) is expressed in HEK2... | |||
TMPK-01485 |
HLA-A*01:01&B2M&DSG3 (YTDNWLAVY) Monomer Protein, Human, MHC (His & Avi)
CDHF6,DG3,DSG3,PVA,DSG-3,Desmoglein-3 |
Human | HEK293 Cells |
DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. DSG3 is identified overexpressed in HNC, with the degree of overexpression associated with clinicopathologic features of the tumor. Inhibition of DSG3 significantly suppresses carcinogenic potential in cellular and in vivo animal studies. These findings suggest that DSG3 is a potential molecular target in the development of adjuvant therapy for HNC. |